Nonarteritic anterior ischemic optic neuropathy

Current Opinion in Ophthalmology

Volumn 16, Issue 6, 2005, Pages 341-345

  Mathews, Michaela Kunz ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Anterior ischemic optic neuropathy; Atherosclerosis; Cholesterol; Neuroprotection

Indexed keywords

ANTICOAGULANT AGENT; CARBIDOPA; CORTICOSTEROID; LEVODOPA; NEUROPROTECTIVE AGENT; OXYGEN; PHENYTOIN;

ATHEROSCLEROSIS; CILIARY ARTERY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DECOMPRESSION SURGERY; DIABETES MELLITUS; DISEASE COURSE; HEMOCONCENTRATION; HEMODILUTION; HUMAN; HYPERBARIC OXYGEN; HYPERCOAGULABILITY; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; ISCHEMIC OPTIC NEUROPATHY; NERVE SHEATH; OPTIC DISK; OPTIC NERVE DISEASE; OPTIC NERVE LESION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ARTERITIS; HUMANS; OPTIC NEUROPATHY, ISCHEMIC; RISK FACTORS;

EID: 28444487505     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000188361.52166.93     Document Type: Review

References (35)

1. Repka M, Savino P, Schatz N, Sergott R. Clinical profile and long-term implications of anterior ischemie optic neuropathy. Am J Ophthalmol 1983; 96:478-483.
2. Chutorian AB, Winterkorn JMS, Geffner M. Anterior ischemic optic neuropathy in children: case report and review of the literature. Pediatr Neurol 2002; 26:358-364.
3. Hattenhauer M, Leavitt J, Hodge D, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123:103-107.
4. IONDT Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366-1374.
5. Newman N, Scherer R, Kelman S, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134:317-328.
6. Cheng M, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery 2000; 46:625-630. [discussion 630-631]
7. Williams E, Hart J, Tempelhoff R. Postoperative ischemic optic neuropathy. Anesth Analg 1995; 80:1018-1020.
8. Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 1995; 15:9-10.
9. Rizzo J, Andreoli C, Rabinov J. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic ischemic optic neuropathy. Ophthalrnology 2002; 109:1679-1684. This study emphasizes the radiographic differences between optic neuritis and NAION and provides an important diagnostic tool for differentiation of the two diseases.
10. Olver J, Spalton D, McCartney A. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischemic optic neuropathy. Eye 1990; 4:7-24.
11. Beck R, Savino P, Repka M, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984; 91:1334-1337.
12. Johnson M, Kincaid M, Trobe J. Bilateral retrobulbar optic nerve infarctions after blood loss and hypotension. A clinicopathologic case study. Ophthalmology 1978; 94:1577-1584.
13. Conolly S, Gordon K, Horton J. Salvage of vision after hypotension induced ischemic optic neuropathy. Am J Ophthalmol 1994; 117:235-242.
14. Arnold A. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003; 23:157-163. This is an excellent review on the pathogenesis of NAION. It summarizes recent relevant studies in a concise and organized fashion.
15. Deramo VA, Sergott RC, Augsburger JJ, et al. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology 2003; 110:1041-1045.
16. Mojon D 3rd, Ehrenberg B, Karam E, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002; 120:601-605.
17. Behbehani R, Mathews M, Sergott R, Savino P. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 2005; 139:518-521.
18. Hayreh S, Zimmerman M, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117:603-624.
19. Chung S, Gay C, McCrary J. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmology 1994; 101:779-782.
20. Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000; 118:291-292.
21. Pomeranz H, Bhavsar A. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005; 25:9-13.
22. Knox D, Duke J. Slowly progressive ischemic optic neuropathy. Trans Am Acad Ophthalmol Otolaryngol 1971; 75:1065-1068.
23. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000; 98:203-222. [discussion 221-222] This is a detailed histopathologic study of ischemic optic neuropathy with a host of impressive images on the topic.
24. Arnold A, Hepler R. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 117:222-230.
25. Oto S, Yilmaz G, Cakmakci S, Aydin P. Indocyanine green and fluorescein angiography in nonarteritic anterior ischemic optic neuropathy. Retina 2002; 22:187-191.
26. Flaharty PM, Sergott RC, Lieb W, et al. Optic nerve sheath decompression may improve blood flow in anterior ischemic optic neuropathy. Ophthalmology 1993; 100:297-305.
27. Tesser R, Niendorf E, Levin L. The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2003; 110:2031-2035.
28. Levin L, Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114:488-491.
29. IONDT Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995; 273:625-632.
30. Arnold A, Levin L. Treatment of ischemic optic neuropathy. Semin Ophthalmol 2002; 17:39-46. The authors reviewed past, present and future treatment strategies for NAION, including detailed background and rationale for neuroprotective treatment strategies.
31. Johnson L, Gould T, Krobel G. Effect of levodopa and carbidopa on recovery of visual function in patients with non arteriticanterior ischemic optic neuropathy of longer than six months duration. Am J Ophthalmol 1996; 121:77-83.
32. Simsek T, Eryilmaz T, Acaroglu G. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy, Int J Clin Pract 2005; 59:287-290.
33. Wheeler L, Lai R, Woldemussie E. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur J Ophthalmol 1999; (Suppl 1):S17-S21.
34. Wilhelm B, Ludtke H, Wilhelm H. Group TBs. Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 2005; 8:1-8. One of the most recent publications on neuroprotection. Succinct discussion on the difficulties encountered in evaluating this treatment.
35. Bernstein SL, Guo Y, Kelman S, et al. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003; 44:4153-4162.